TELYF (TelyRx Holdings) Shares Buyback Ratio %: -7.69 (As of Aug. 30, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TELYF TelyRx Holdings Inc TELYF
12 GF Score
Price $1.88
! 2 Warning Signs
View Full Analysis

What is TelyRx Holdings Shares Buyback Ratio %?

TelyRx Holdings TELYF +1.62% 12 Shares Buyback Ratio % is -7.69 as of Aug. 30, 2026. GuruFocus rates TELYF with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. TelyRx Holdings's current shares buyback ratio was -7.69%.

TelyRx Holdings Shares Buyback Ratio % Related Terms

TelyRx Holdings Shares Buyback Ratio % Historical Data

* Premium members only.

The historical data trend for TelyRx Holdings's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TelyRx Holdings Shares Buyback Ratio % Chart

TelyRx Holdings Annual Data
Trend Dec23 Dec24 Dec25
Shares Buyback Ratio %
0.00 0.00 0.00

TelyRx Holdings Quarterly Data
Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 -7.65 -0.04
TELYF
12GF Score
TelyRx Holdings Inc TELYF
Shares Buyback Ratio % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TelyRx Holdings Shares Buyback Ratio % Calculation

TelyRx Holdings's Shares Buyback Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2024 ) - Shares Outstanding (EOP) (A: Dec. 2025 )) / Shares Outstanding (EOP) (A: Dec. 2024 )
=(24.691 - 24.691) / 24.691
=0.00%

TelyRx Holdings's Shares Buyback Ratio for the quarter that ended in Jun. 2026 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Mar. 2026 ) - Shares Outstanding (EOP) (A: Jun. 2026 )) / Shares Outstanding (EOP) (A: Mar. 2026 )
=(26.579 - 26.590) / 26.579
=-0.04%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Shares Buyback Ratio % →
What does a Shares Buyback Ratio % of -7.69 mean?
TelyRx Holdings (TELYF) has a Shares Buyback Ratio % of -7.69 as of Aug. 30, 2026. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on TelyRx Holdings and its competitors.
Is TelyRx Holdings' Shares Buyback Ratio % too high?
TelyRx Holdings' current Shares Buyback Ratio % is -7.69. Overall, TelyRx Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TelyRx Holdings' Shares Buyback Ratio % compare to ?
TelyRx Holdings' Shares Buyback Ratio % of -7.69 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Buyback Ratio % for a Healthcare Providers & Services company?
A good Shares Buyback Ratio % depends on the Healthcare Providers & Services industry context. However, Shares Buyback Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Buyback Ratio % mean?
A high Shares Buyback Ratio % can signal that a stock is expensive relative to its fundamentals. Share buyback ratio is the percent change of a company's shares outstanding from two periods. View historical data on TelyRx Holdings and its competitors. TelyRx Holdings's current Shares Buyback Ratio % is -7.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TelyRx Holdings stock overvalued right now?
TelyRx Holdings (TELYF) has a current Shares Buyback Ratio % of -7.69. The current Shares Buyback Ratio % is -7.69. TelyRx Holdings' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Buyback Ratio % calculated?
Shares Buyback Ratio % is calculated from a company's financial statements. For TelyRx Holdings (TELYF), the current Shares Buyback Ratio % is -7.69 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TelyRx Holdings Business Description

Comparable Companies
Other Exchanges TELY:Canada
Address 24761 US Highway 19 North, Clearwater, FL, USA, 33763
TelyRx Holdings Inc is a vertically integrated technology enabled healthcare and pharmacy services provider, operating a digital pharmacy platform that connects patients with independent, state-licensed providers. The TelyRx platform provides the Providers with access to a clinically focused electronic medical records system and the ability for them to electronically prescribe. TelyRx enables patient access to a risk-curated formulary of over 450 noncontrolled, and non-compounded prescription medications selected by the Providers to address a broad cross-section of everyday chronic and acute ailments.
12GF Score

Get the complete analysis for TELYF

Shares Buyback Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.88
Price